Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.04
GNC's Cash to Debt is ranked lower than
94% of the 363 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.53 vs. GNC: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
GNC' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.14 Max: N/A
Current: 0.04
Equity to Asset 0.11
GNC's Equity to Asset is ranked lower than
95% of the 362 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. GNC: 0.11 )
Ranked among companies with meaningful Equity to Asset only.
GNC' s Equity to Asset Range Over the Past 10 Years
Min: 0.11  Med: 0.29 Max: 0.42
Current: 0.11
0.11
0.42
Interest Coverage 9.62
GNC's Interest Coverage is ranked lower than
59% of the 331 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.76 vs. GNC: 9.62 )
Ranked among companies with meaningful Interest Coverage only.
GNC' s Interest Coverage Range Over the Past 10 Years
Min: 2.02  Med: 6.40 Max: 10.74
Current: 9.62
2.02
10.74
F-Score: 5
Z-Score: 2.80
M-Score: -2.87
WACC vs ROIC
5.17%
12.89%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 14.31
GNC's Operating margin (%) is ranked higher than
95% of the 364 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.98 vs. GNC: 14.31 )
Ranked among companies with meaningful Operating margin (%) only.
GNC' s Operating margin (%) Range Over the Past 10 Years
Min: 10.24  Med: 14.26 Max: 17.61
Current: 14.31
10.24
17.61
Net-margin (%) 7.84
GNC's Net-margin (%) is ranked higher than
93% of the 365 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.78 vs. GNC: 7.84 )
Ranked among companies with meaningful Net-margin (%) only.
GNC' s Net-margin (%) Range Over the Past 10 Years
Min: 3.3  Med: 7.35 Max: 10.08
Current: 7.84
3.3
10.08
ROE (%) 36.60
GNC's ROE (%) is ranked higher than
96% of the 359 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.83 vs. GNC: 36.60 )
Ranked among companies with meaningful ROE (%) only.
GNC' s ROE (%) Range Over the Past 10 Years
Min: 5.78  Med: 22.62 Max: 35.82
Current: 36.6
5.78
35.82
ROA (%) 7.89
GNC's ROA (%) is ranked higher than
82% of the 366 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.32 vs. GNC: 7.89 )
Ranked among companies with meaningful ROA (%) only.
GNC' s ROA (%) Range Over the Past 10 Years
Min: 2.38  Med: 6.92 Max: 10.02
Current: 7.89
2.38
10.02
ROC (Joel Greenblatt) (%) 54.85
GNC's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 364 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.57 vs. GNC: 54.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GNC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 35.42  Med: 54.05 Max: 73.51
Current: 54.85
35.42
73.51
Revenue Growth (3Y)(%) 10.60
GNC's Revenue Growth (3Y)(%) is ranked higher than
78% of the 320 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.00 vs. GNC: 10.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
GNC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 10.60 Max: 16.1
Current: 10.6
0
16.1
EBITDA Growth (3Y)(%) 5.60
GNC's EBITDA Growth (3Y)(%) is ranked higher than
52% of the 289 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.90 vs. GNC: 5.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
GNC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 19.50 Max: 28
Current: 5.6
0
28
EPS Growth (3Y)(%) 4.30
GNC's EPS Growth (3Y)(%) is ranked lower than
55% of the 258 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.20 vs. GNC: 4.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
GNC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 31.30 Max: 58.1
Current: 4.3
0
58.1
» GNC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

GNC Guru Trades in Q2 2015

Joel Greenblatt 519,395 sh (+13.37%)
RS Investment Management 646,013 sh (+6.04%)
Steven Cohen Sold Out
Mario Gabelli 6,780 sh (-0.59%)
Private Capital 407,574 sh (-0.61%)
Jim Simons 308,300 sh (-43.32%)
Richard Snow 6,500 sh (-45.38%)
» More
Q3 2015

GNC Guru Trades in Q3 2015

Paul Tudor Jones 6,644 sh (New)
John Hussman 100,000 sh (New)
Jim Simons 907,890 sh (+194.48%)
Joel Greenblatt 1,302,540 sh (+150.78%)
Mario Gabelli 6,780 sh (unchged)
Richard Snow Sold Out
Private Capital 404,644 sh (-0.72%)
RS Investment Management 430,583 sh (-33.35%)
» More
Q4 2015

GNC Guru Trades in Q4 2015

Steven Cohen 769,800 sh (New)
Louis Moore Bacon 500,000 sh (New)
Joel Greenblatt 1,919,705 sh (+47.38%)
Mario Gabelli 7,100 sh (+4.72%)
Private Capital 407,864 sh (+0.80%)
John Hussman Sold Out
Paul Tudor Jones Sold Out
RS Investment Management Sold Out
Jim Simons 433,580 sh (-52.24%)
» More
Q1 2016

GNC Guru Trades in Q1 2016

Mario Gabelli 8,300 sh (+16.90%)
Louis Moore Bacon Sold Out
Private Capital 401,972 sh (-1.44%)
Steven Cohen 545,333 sh (-29.16%)
Jim Simons 205,900 sh (-52.51%)
Joel Greenblatt 281,725 sh (-85.32%)
» More
» Details

Insider Trades

Latest Guru Trades with GNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:OTCPK:CLCGY, OTCPK:JCOUF, OTCPK:CLIGF, NAS:PETS, OTCBB:COCP, OTCPK:CRPNF, NYSE:NPD, NAS:CJJD, OTCPK:HEWA, OTCPK:SDGCF, NYSE:RAD, NAS:WBA » details
Traded in other countries:IGN.Germany,
GNC Holdings Inc is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products.

GNC Holdings Inc was founded in 1935. It is a specialty retailer of health and wellness products, including VMHS products, sports nutrition products, and diet products. The Company's business segments include: Retail, Franchising and Manufacturing/Wholesale. Its retail segment is engaged in sales of products to customers at its company-owned stores in the United States, Canada and Puerto Rico and through its websites, GNC.com, LuckyVitamin.com and DiscountSupplements.com. As of December 31, 2015, the Company operated 3,594 company-owned stores across all 50 states including the District of Columbia, Canada and Puerto Rico. Its franchise segment consists of its domestic and international franchise operations, and engaged in franchise activities mainly product sales to franchisees, royalties on franchise retail sales and franchise fees. As of December 31, 2015, there were 3,169 franchise stores operating, including 1,084 stores in the U.S. and 2,085 international franchise stores operating in over 50 international countries. Its franchise stores in the United States offer both its proprietary products and third-party products, with a product selection similar to that of its company-owned stores. Its international franchise stores are offered a more limited product selection than its franchise stores in the United States with the product selection heavily weighted toward proprietary products. Manufacturing/Wholesale segment consists of manufacturing operations in South Carolina and its wholesale sales business. This segment supplies its Retail and Franchise segments as well as various third parties with finished products. Its Manufacturing/Wholesale segment is engaged in sales of manufactured products to third parties, and the sale of its proprietary and third-party brand products to Rite Aid, Sam's Club, PetSmart and www.drugstore.com. Its wholesale operations are supported mainly by its Anderson, South Carolina distribution center. The Company's sales are in four nutritional supplement categories: VMHS, sports nutrition, diet and other wellness. It offers high-quality nutritional supplements sold under its GNC proprietary brand names, including Mega Men, Ultra Mega, Total LeanTM, Pro Performance and Pro Performance AMP, Beyond Raw and under nationally recognized third-party brand names. Its online channels are, GNC.com, LuckyVitamin.com and DiscountSupplements.com. It competes with other specialty retailers, supermarkets, drugstores, mass merchants, multi-level marketing organizations, mail-order companies, other internet sites and a variety of other smaller participants. The Company is subject to also subject to regulation under various national, local and international laws.

Ratios

vs
industry
vs
history
P/E(ttm) 7.94
GNC's P/E(ttm) is ranked higher than
84% of the 334 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.50 vs. GNC: 7.94 )
Ranked among companies with meaningful P/E(ttm) only.
GNC' s P/E(ttm) Range Over the Past 10 Years
Min: 7.89  Med: 17.00 Max: 31.9
Current: 7.94
7.89
31.9
Forward P/E 6.92
GNC's Forward P/E is ranked higher than
97% of the 92 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.32 vs. GNC: 6.92 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 7.94
GNC's PE(NRI) is ranked higher than
84% of the 308 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.27 vs. GNC: 7.94 )
Ranked among companies with meaningful PE(NRI) only.
GNC' s PE(NRI) Range Over the Past 10 Years
Min: 7.89  Med: 17.00 Max: 31.9
Current: 7.94
7.89
31.9
Price/Owner Earnings (ttm) 5.10
GNC's Price/Owner Earnings (ttm) is ranked higher than
89% of the 198 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.94 vs. GNC: 5.10 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
GNC' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.09  Med: 14.36 Max: 21.28
Current: 5.1
6.09
21.28
P/B 4.85
GNC's P/B is ranked lower than
92% of the 390 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.81 vs. GNC: 4.85 )
Ranked among companies with meaningful P/B only.
GNC' s P/B Range Over the Past 10 Years
Min: 2.17  Med: 4.76 Max: 8.2
Current: 4.85
2.17
8.2
P/S 0.67
GNC's P/S is ranked lower than
69% of the 385 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.47 vs. GNC: 0.67 )
Ranked among companies with meaningful P/S only.
GNC' s P/S Range Over the Past 10 Years
Min: 0.65  Med: 1.55 Max: 2.32
Current: 0.67
0.65
2.32
PFCF 4.92
GNC's PFCF is ranked higher than
89% of the 179 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.72 vs. GNC: 4.92 )
Ranked among companies with meaningful PFCF only.
GNC' s PFCF Range Over the Past 10 Years
Min: 4.9  Med: 19.71 Max: 34.38
Current: 4.92
4.9
34.38
POCF 4.26
GNC's POCF is ranked higher than
81% of the 223 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.62 vs. GNC: 4.26 )
Ranked among companies with meaningful POCF only.
GNC' s POCF Range Over the Past 10 Years
Min: 4.25  Med: 15.48 Max: 25.08
Current: 4.26
4.25
25.08
EV-to-EBIT 7.60
GNC's EV-to-EBIT is ranked higher than
81% of the 334 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.92 vs. GNC: 7.60 )
Ranked among companies with meaningful EV-to-EBIT only.
GNC' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 12.30 Max: 16.5
Current: 7.6
7.6
16.5
EV-to-EBITDA 6.63
GNC's EV-to-EBITDA is ranked higher than
74% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.10 vs. GNC: 6.63 )
Ranked among companies with meaningful EV-to-EBITDA only.
GNC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.6  Med: 10.80 Max: 14.3
Current: 6.63
6.6
14.3
PEG 0.61
GNC's PEG is ranked higher than
93% of the 166 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.28 vs. GNC: 0.61 )
Ranked among companies with meaningful PEG only.
GNC' s PEG Range Over the Past 10 Years
Min: 0.46  Med: 0.68 Max: 1
Current: 0.61
0.46
1
Current Ratio 2.21
GNC's Current Ratio is ranked higher than
84% of the 349 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.19 vs. GNC: 2.21 )
Ranked among companies with meaningful Current Ratio only.
GNC' s Current Ratio Range Over the Past 10 Years
Min: 2.21  Med: 3.11 Max: 3.91
Current: 2.21
2.21
3.91
Quick Ratio 0.68
GNC's Quick Ratio is ranked lower than
54% of the 349 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.72 vs. GNC: 0.68 )
Ranked among companies with meaningful Quick Ratio only.
GNC' s Quick Ratio Range Over the Past 10 Years
Min: 0.68  Med: 1.23 Max: 1.85
Current: 0.68
0.68
1.85
Days Inventory 122.28
GNC's Days Inventory is ranked lower than
93% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 40.05 vs. GNC: 122.28 )
Ranked among companies with meaningful Days Inventory only.
GNC' s Days Inventory Range Over the Past 10 Years
Min: 111.33  Med: 118.20 Max: 124.85
Current: 122.28
111.33
124.85
Days Sales Outstanding 17.56
GNC's Days Sales Outstanding is ranked lower than
56% of the 288 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.79 vs. GNC: 17.56 )
Ranked among companies with meaningful Days Sales Outstanding only.
GNC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.05  Med: 19.67 Max: 20.17
Current: 17.56
19.05
20.17
Days Payable 45.69
GNC's Days Payable is ranked higher than
52% of the 287 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 45.05 vs. GNC: 45.69 )
Ranked among companies with meaningful Days Payable only.
GNC' s Days Payable Range Over the Past 10 Years
Min: 28.85  Med: 30.94 Max: 41.66
Current: 45.69
28.85
41.66

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.72
GNC's Dividend Yield is ranked higher than
69% of the 458 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.92 vs. GNC: 3.72 )
Ranked among companies with meaningful Dividend Yield only.
GNC' s Dividend Yield Range Over the Past 10 Years
Min: 0.27  Med: 1.37 Max: 3.75
Current: 3.72
0.27
3.75
Dividend Payout 0.29
GNC's Dividend Payout is ranked higher than
69% of the 274 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.32 vs. GNC: 0.29 )
Ranked among companies with meaningful Dividend Payout only.
GNC' s Dividend Payout Range Over the Past 10 Years
Min: 0.18  Med: 0.23 Max: 0.33
Current: 0.29
0.18
0.33
Dividend Growth (3y) 17.80
GNC's Dividend Growth (3y) is ranked higher than
79% of the 184 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.30 vs. GNC: 17.80 )
Ranked among companies with meaningful Dividend Growth (3y) only.
GNC' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 17.8
Current: 17.8
0
17.8
Forward Dividend Yield 3.92
GNC's Forward Dividend Yield is ranked higher than
65% of the 423 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.89 vs. GNC: 3.92 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 3.74
GNC's Yield on cost (5-Year) is ranked higher than
51% of the 465 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.78 vs. GNC: 3.74 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
GNC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.27  Med: 1.37 Max: 3.75
Current: 3.74
0.27
3.75
3-Year Average Share Buyback Ratio 8.40
GNC's 3-Year Average Share Buyback Ratio is ranked higher than
98% of the 202 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.60 vs. GNC: 8.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
GNC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 5.60 Max: 0
Current: 8.4
-4.1
0

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.46
GNC's Price/Projected FCF is ranked higher than
81% of the 226 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.42 vs. GNC: 0.46 )
Ranked among companies with meaningful Price/Projected FCF only.
GNC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.72  Med: 1.04 Max: 1.97
Current: 0.46
0.72
1.97
Price/Median PS Value 0.41
GNC's Price/Median PS Value is ranked higher than
91% of the 366 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.06 vs. GNC: 0.41 )
Ranked among companies with meaningful Price/Median PS Value only.
GNC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 1.01 Max: 1.41
Current: 0.41
0.63
1.41
Price/Peter Lynch Fair Value 0.52
GNC's Price/Peter Lynch Fair Value is ranked higher than
90% of the 94 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.79 vs. GNC: 0.52 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
GNC' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.67  Med: 0.76 Max: 0.87
Current: 0.52
0.67
0.87
Earnings Yield (Greenblatt) (%) 13.06
GNC's Earnings Yield (Greenblatt) (%) is ranked higher than
84% of the 398 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.00 vs. GNC: 13.06 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GNC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.1  Med: 8.10 Max: 13.09
Current: 13.06
6.1
13.09
Forward Rate of Return (Yacktman) (%) 24.17
GNC's Forward Rate of Return (Yacktman) (%) is ranked higher than
88% of the 224 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.30 vs. GNC: 24.17 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
GNC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 22  Med: 24.55 Max: 36.9
Current: 24.17
22
36.9

More Statistics

Revenue (TTM) (Mil) $2,638
EPS (TTM) $ 2.57
Beta0.76
Short Percentage of Float8.57%
52-Week Range $19.31 - 51.69
Shares Outstanding (Mil)68.37

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 2,628 2,683 2,797
EPS ($) 2.98 3.12 3.50
EPS w/o NRI ($) 2.98 3.12 3.50
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($) 0.72 0.72
» More Articles for NYSE:GNC

Headlines

Articles On GuruFocus.com
Stocks Mario Gabelli Has Bought for 2 Quarters Jun 20 2016 
Lessons From Valeant Mar 22 2016 
Private Capital Reduces Holdings in Healthcare Stocks Dec 18 2014 
Why GNC Holdings Is a Good Buy Despite a Mixed Quarter Nov 30 2014 
Why Investors Should Expect a Turnaround at GNC Holdings Nov 18 2014 
These Health Retailers Are Enticing Long-Term Bets Aug 06 2014 
GNC Could Generate a 55% Return May 08 2014 
Herbalife and GNC Are Good Investments, Here’s Why Apr 17 2014 
Top 5 Stocks from TPG-Axon Mar 21 2013 
Billionaire Steven Cohen Vitamins Up with GNC Mar 04 2013 

More From Other Websites
GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View Jul 29 2016
GNC Stock Price Target Lowered at Jefferies Jul 29 2016
GNC Holdings Pulls Its Guidance as Its CEO Resigns Jul 29 2016
GNC paying interim CEO monthly salary of $83K plus cash incentive and use of corporate jet Jul 29 2016
GNC Holdings, Inc. breached its 50 day moving average in a Bearish Manner : GNC-US : July 29, 2016 Jul 29 2016
[$$] GNC’s CEO Out as Sales, Earnings Continue to Slide Jul 29 2016
GNC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 28 2016
Infinera, GNC Join Thursday’s 52-Week Low Club Jul 28 2016
[$$] GNC's CEO Leaves as It Suspends Guidance Jul 28 2016
GNC Goes South After C-Suite Shake-Up Jul 28 2016
GNC's interim CEO: Board 'determined change was needed' Jul 28 2016
GNC CEO steps down, guidance suspended, shares plunge Jul 28 2016
GNC CEO steps down, guidance suspended, shares plunge Jul 28 2016
GNC Holdings downgraded by Piper Jaffray Jul 28 2016
GNC Stock Plummets After CEO Archbold Leaves Jul 28 2016
GNC Holdings (GNC) Tops Q2 Earnings and Revenues Jul 28 2016
GNC Holdings Inc Earnings Call scheduled for 8:30 am ET today Jul 28 2016
GNC CEO Archbold leaving company Jul 28 2016
GNC Holdings, Inc. Reports Second Quarter 2016 Results Jul 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)